Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
VTS | Ann: Distribution FX Rate Announcement | 18/04/24 | 0 | 54 | |||
|
|||||||
VTS | Ann: Outstanding ETF Securities Announcement | 05/04/24 | 0 | 55 | |||
|
|||||||
VTS | Ann: Final Distribution Announcement | 21/03/24 | 0 | 121 | |||
|
|||||||
VTS | Ann: US SEC Filing Announcement - N-CEN | 14/03/24 | 0 | 93 | |||
|
|||||||
VTS | Ann: Distribution Timetable Announcement | 12/03/24 | 0 | 90 | |||
|
|||||||
VTS | Ann: Outstanding ETF Securities Announcement | 04/03/24 | 0 | 104 | |||
|
|||||||
VTS | Ann: US SEC Filing Announcement - N-PORT | 01/03/24 | 0 | 90 | |||
|
|||||||
VTS | Ann: US SEC Filing Announcement - N-CSR Annual report | 01/03/24 | 0 | 83 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |